Results 241 to 250 of about 13,239,682 (316)

Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long‐chain fatty acid accumulation after myocardial ischemia–reperfusion in mice

FEBS Open Bio, EarlyView.
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin, Naghme Radmannia, David N. Huynh, Liliane Ménard, Caroline Daneault, Maïté Veilleux, Ahsanullah Ahsanullah, André C. Carpentier, William D. Lubell, Matthieu Ruiz, Huy Ong, Sylvie Marleau, Simon‐Pierre Gravel   +12 more
wiley   +1 more source

The utility of a composite endpoint for tracking disease progression in Lewy body dementia. [PDF]

Alzheimers Dement (N Y)
Matar E, White SR, Taylor JP, Thomas A, McKeith I, Kane J, Lewis S, Surendranathan A, O'Brien J.   +8 more
europepmc   +1 more source

UiO‐66 metal–organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy

FEBS Open Bio, EarlyView.
UiO‐66(Zr) metal–organic frameworks are chemically stable, biocompatible, and highly tunable nanomaterials. Their modular structure enables controlled drug delivery, multimodal bioimaging, and light‐activated photodynamic therapy, supporting integrated diagnostic and therapeutic (theranostic) applications in cancer and biomedical research.
Veronika Huntošová, Grigorii Rakhalskii, Miroslav Almáši   +2 more
wiley   +1 more source

Disease progression modeling of Alzheimer's disease based on variational probability principal component analysis. [PDF]

PLoS One
Xiong X, Wang X, Zhu C, He J, Alzheimer’s Disease Neuroimaging Initiative.   +4 more
europepmc   +1 more source

METTL7A is a key regulator of hepatic lipid metabolism and nonalcoholic fatty liver disease progression. [PDF]

Sci Rep
Chen F, Yao L, Yang L, Li X, Zhou J, Li D, Wu Z, Chen P.   +7 more
europepmc   +1 more source

Visual cognition as a marker of longitudinal disease progression in Huntington's disease. [PDF]

Int J Clin Health Psychol
Pino RD, Acera MÁ, Murueta-Goyena A, Tijero B, Ruiz-Lopez M, Somme J, Ruiz J, Gabilondo A, Sánchez-Pernaute R, Gabilondo I, Fernández-Valle T, Esteban JCG.   +11 more
europepmc   +1 more source

Flexible Multimodal Neuroimaging Fusion for Alzheimer's Disease Progression Prediction. [PDF]

Appl Med Artif Intel (2025)
Burns B, Xue Y, Scharre DW, Ning X.
europepmc   +1 more source

Determinants and management approaches for fear of disease progression among stroke survivors. [PDF]

Medicine (Baltimore)
Liu X, Qin L, Zhong J.
europepmc   +1 more source

SGO1 and SGO2 are Associated With Disease Progression and an Immunosuppressive Microenvironment in Papillary Renal Cell Carcinoma. [PDF]

Cancer Med
Fu H, Ibrohimov A, Zheng H, Pan Y, Hu J, Ruan B, Huang H, Li S.   +7 more
europepmc   +1 more source